NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance
Nature · 18.07.2024 · 631 (8021) · 663-669
DOI: 10.1038/s41586-024-07620-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 03.07.2024. Verfasst von Hengxing Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, Chi…. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Drug Resistance, Neoplasm, Lactic Acid, Nuclear Proteins. Die Arbeit wurde bisher 626-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
The Warburg effect is a hallmark of cancer that refers to the preference of cancer cells to metabolize glucose anaerobically rather than aerobically 1,2 . This results in substantial accumulation of lacate, the end product of anaerobic glycolysis, in cancer cells 3 . However, how cancer metabolism affects chemotherapy response and DNA repair in general remains incompletely understood. Here we report that lactate-driven lactylation of NBS1 promotes homologous recombination (HR)-mediated DNA repair. Lactylation of NBS1 at lysine 388 (K388) is essential for MRE11–RAD50–NBS1 (MRN) complex formation and the accumulation of HR repair proteins at the sites of DNA double-strand breaks. Furthermore, we identify TIP60 as the NBS1 lysine lactyltransferase and the ‘writer’ of NBS1 K388 lactylation, and HDAC3 as the NBS1 de-lactylase. High levels of NBS1 K388 lactylation predict poor patient outcome of neoadjuvant chemotherapy, and lactate reduction using either genetic depletion of lactate dehydrogenase A (LDHA) or stiripentol, a lactate dehydrogenase A inhibitor used clinically for anti-epileptic treatment, inhibited NBS1 K388 lactylation, decreased DNA repair efficacy and overcame resistance to chemotherapy. In summary, our work identifies NBS1 lactylation as a critical mechanism for genome stability that contributes to chemotherapy resistance and identifies inhibition of lactate production as a promising therapeutic cancer strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China.
- Cancer Stem Cell Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China. heyulong@mail.sysu.edu.cn.
Zitieren
APA
Chen, H., Li, Y., Li, H., Chen, X., Fu, H., Mao, D., Chen, W., Lan, L., Wang, C., Hu, K., Li, J., Zhu, C., Evans, I., Cheung, E., Lu, D., He, Y., Behrens, A., Yin, D., & Zhang, C. (2024). NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature, 631(8021), 663-669. https://doi.org/10.1038/s41586-024-07620-9
Vancouver
Chen H, Li Y, Li H, Chen X, Fu H, Mao D, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663-669. doi:10.1038/s41586-024-07620-9
BibTeX
@article{Chen2024,
author = {Chen, Hengxing and Li, Yun and Li, Huafu and Chen, Xiancong and Fu, Huafeng and Mao, Deli and Chen, Wei and Lan, Linxiang and Wang, Chunming and Hu, Kaishun and Li, Jia and Zhu, Chengming and Evans, Ian and Cheung, Eddie and Lu, Daning and He, Yulong and Behrens, Axel and Yin, Dong and Zhang, Changhua},
title = {NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance},
journal = {Nature},
year = {2024},
volume = {631},
number = {8021},
pages = {663--669},
doi = {10.1038/s41586-024-07620-9}
}
EUVIMED